Diagnosing and Treating Alzheimer Disease: August's Key Developments

Alzheimer disease research and care advanced on multiple fronts this August, from new blood-based and imaging diagnostics to early-phase therapeutic data and expert perspective on evolving clinical practice. This recap rounds up key developments, including FDA actions on diagnostic tools, emerging pipeline results, and clinical guidance on benzodiazepine use in older adults amid ongoing questions about dementia risk.